TY - JOUR
T1 - Hepatic metabolism during constant infusion of fructose; comparative studies with 31P-magnetic resonance spectroscopy in man and rats
AU - Masson, Serge
AU - Henriksen, Ole
AU - Stengaard, Anders
AU - Thomsen, Carsten
AU - Quistorff, Bjørn
PY - 1994/3/2
Y1 - 1994/3/2
N2 - A protocol of constant infusion of fructose has been carried out both in human volunteers and in the perfused rat liver, aiming at a steady-state blood fructose concentration of 6-8 mM. Localized 31P-NMR spectroscopy and biochemical analyses were used to evaluate the metabolic changes. Comparison of the model experiment and the clinical study allowed an evaluation of this protocol as a clinically relevant assessment of the metabolic function of the liver. The time course of change, as well as the quasi steady-state levels reached during fructose infusion, for phosphomonoesters (PME), ATP and inorganic phosphate (Pi) provided the following results: During fructose infusion, ATP and Pi reached a steady-state level of 74.0 ± 5.9 and 54.6 ± 3.3% of control respectively, in the human volunteers. The corresponding data in the rat liver was 71.3 ± 4.3 and 54.4 ± 4.3%. Hepatic clearance of fructose was 0.53 and 0.52 ml · gl liver-1 · min-1 for volunteers and rats, respectively. The time course of intracellular metabolite recovery after fructose could be approximated by a first order kinetic. The rate constants for PME and ATP change were similar during fructose infusion and recovery, while after the discontinuation of fructose infusion Pi increased with a rate constant significantly greater than during its fructose-induced depletion in human liver (P < 0.005). Thus, this relatively simple clinically applicable protocol seems to be verifiable in the well controlled perfused rat liver model, and it is argued that it may be useful in the clinical evaluation of the metabolic functional capacity of the human liver.
AB - A protocol of constant infusion of fructose has been carried out both in human volunteers and in the perfused rat liver, aiming at a steady-state blood fructose concentration of 6-8 mM. Localized 31P-NMR spectroscopy and biochemical analyses were used to evaluate the metabolic changes. Comparison of the model experiment and the clinical study allowed an evaluation of this protocol as a clinically relevant assessment of the metabolic function of the liver. The time course of change, as well as the quasi steady-state levels reached during fructose infusion, for phosphomonoesters (PME), ATP and inorganic phosphate (Pi) provided the following results: During fructose infusion, ATP and Pi reached a steady-state level of 74.0 ± 5.9 and 54.6 ± 3.3% of control respectively, in the human volunteers. The corresponding data in the rat liver was 71.3 ± 4.3 and 54.4 ± 4.3%. Hepatic clearance of fructose was 0.53 and 0.52 ml · gl liver-1 · min-1 for volunteers and rats, respectively. The time course of intracellular metabolite recovery after fructose could be approximated by a first order kinetic. The rate constants for PME and ATP change were similar during fructose infusion and recovery, while after the discontinuation of fructose infusion Pi increased with a rate constant significantly greater than during its fructose-induced depletion in human liver (P < 0.005). Thus, this relatively simple clinically applicable protocol seems to be verifiable in the well controlled perfused rat liver model, and it is argued that it may be useful in the clinical evaluation of the metabolic functional capacity of the human liver.
KW - (Rat)
KW - P-NMR spectroscopy
KW - Fructose
KW - Human study
KW - Liver function
KW - Liver perfusion
UR - http://www.scopus.com/inward/record.url?scp=0028324203&partnerID=8YFLogxK
U2 - 10.1016/0304-4165(94)90112-0
DO - 10.1016/0304-4165(94)90112-0
M3 - Article
C2 - 8123666
AN - SCOPUS:0028324203
VL - 1199
SP - 166
EP - 174
JO - Biochimica et Biophysica Acta - General Subjects
JF - Biochimica et Biophysica Acta - General Subjects
SN - 0006-3002
IS - 2
ER -